APA (7th ed.) Citation

FJ, H., P, P., E, K., M, H., K, J., A, U., . . . MK, D. (2018). Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: Protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064). Systematic reviews, 7(1), 11. https://doi.org/10.1186/s13643-018-0678-9

Chicago Style (17th ed.) Citation

FJ, Hüttner, Probst P, Kalkum E, Hackbusch M, Jensen K, Ulrich A, Büchler MW, and Diener MK. "Addition of Platinum Derivatives to Neoadjuvant Single-agent Fluoropyrimidine Chemoradiotherapy in Patients with Stage II/III Rectal Cancer: Protocol for a Systematic Review and Meta-analysis (PROSPERO CRD42017073064)." Systematic Reviews 7, no. 1 (2018): 11. https://doi.org/10.1186/s13643-018-0678-9.

MLA (9th ed.) Citation

FJ, Hüttner, et al. "Addition of Platinum Derivatives to Neoadjuvant Single-agent Fluoropyrimidine Chemoradiotherapy in Patients with Stage II/III Rectal Cancer: Protocol for a Systematic Review and Meta-analysis (PROSPERO CRD42017073064)." Systematic Reviews, vol. 7, no. 1, 2018, p. 11, https://doi.org/10.1186/s13643-018-0678-9.